Literature DB >> 24074424

Partial versus total splenectomy in children with hereditary spherocytosis.

Aaron D Seims1, Francine D Breckler, Kyle D Hardacker, Frederick J Rescorla.   

Abstract

BACKGROUND: Partial splenectomy is utilized selectively in children with hereditary spherocytosis (HS) to decrease hemolysis while maintaining immunity. Our aim was to compare outcomes between laparoscopic total splenectomy (LTS) and laparoscopic partial splenectomy (LPS).
METHODS: After obtaining institutional review board approval, we reviewed the records for all children ≤18 years with HS undergoing LTS and LPS between 2002 and 2012. Wilcoxon rank-sum tests were used.
RESULTS: Eighty-seven HS children underwent LTS (n = 71) and LPS (n = 16). Mean age was 7.1 ± 3.6 years (LTS) and 5.5 ± 2.8 years (LPS; P = .14). Concomitant cholecystectomy was performed in 32% of LTS and 38% of LPS cases. Operative time was 87 ± 33 minutes (LTS) and 140 ± 36 minutes (LPS; P = .0005). Duration of stay was 1.2 ± 0.5 days (LTS) and 2.4 ± 1.4 days (LPS; P = .003). Reticulocyte and hemoglobin levels improved after both operations. LPS children had lower preoperative (8.8 ± 1.9 vs 10.2 ± 1.7 g/dL; P = .0148) and postoperative (10.5 ± 1.7 vs 13.8 ± 1.1 g/dL; P < .0001) hemoglobin levels than did LTS patients. Three LPS children required transfusion (at 2, 4 and 5 postoperative years) for parvovirus-associated aplastic crises. No LTS child developed splenic function or anemia.
CONCLUSION: These data demonstrate that LPS decreases hemolysis, although LTS is more effective. LPS children had lower preoperative hemoglobin levels, indicating more severe hemolysis. LPS also has greater operative time and duration of stay, disadvantages balanced by retained immunity.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24074424     DOI: 10.1016/j.surg.2013.07.019

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

Review 1.  Partial splenectomy in the era of minimally invasive surgery: the current laparoscopic and robotic experiences.

Authors:  Alexandre Balaphas; Nicolas C Buchs; Jeremy Meyer; Monika E Hagen; Philippe Morel
Journal:  Surg Endosc       Date:  2015-03-05       Impact factor: 4.584

2.  Hematologic outcomes after total splenectomy and partial splenectomy for congenital hemolytic anemia.

Authors:  Brian R Englum; Jennifer Rothman; Sarah Leonard; Audra Reiter; Courtney Thornburg; Mary Brindle; Nicola Wright; Matthew M Heeney; C Jason Smithers; Rebeccah L Brown; Theodosia Kalfa; Jacob C Langer; Michaela Cada; Keith T Oldham; J Paul Scott; Shawn D St Peter; Mukta Sharma; Andrew M Davidoff; Kerri Nottage; Kathryn Bernabe; David B Wilson; Sanjeev Dutta; Bertil Glader; Shelley E Crary; Melvin S Dassinger; Levette Dunbar; Saleem Islam; Manjusha Kumar; Fred Rescorla; Steve Bruch; Andrew Campbell; Mary Austin; Robert Sidonio; Martin L Blakely; Henry E Rice
Journal:  J Pediatr Surg       Date:  2015-10-23       Impact factor: 2.545

3.  Laparoscopic partial splenectomy: a technical tip.

Authors:  Bruno de la Villeon; Alban Zarzavadjian Le Bian; Helene Vuarnesson; Nicolas Munoz Bongrand; Bruno Halimi; Emile Sarfati; Pierre Cattan; Mircea Chirica
Journal:  Surg Endosc       Date:  2014-06-25       Impact factor: 4.584

4.  Application of the automated haematology analyzer XN-30 in an experimental rodent model of malaria.

Authors:  Takahiro Tougan; Yuhgi Suzuki; Munehisa Izuka; Kei Aono; Tomonori Okazaki; Yuji Toya; Kinya Uchihashi; Toshihiro Horii
Journal:  Malar J       Date:  2018-04-16       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.